Provided by Tiger Trade Technology Pte. Ltd.

Prelude Therapeutics Inc

2.86
+0.09003.25%
Post-market: 2.860.00000.00%19:51 EST
Volume:502.92K
Turnover:1.49M
Market Cap:179.79M
PE:-1.94
High:3.31
Open:2.76
Low:2.68
Close:2.77
52wk High:4.22
52wk Low:0.6101
Shares:62.87M
Float Shares:2.50M
Volume Ratio:1.01
T/O Rate:20.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4708
EPS(LYR):-1.6776
ROE:-103.99%
ROA:-51.82%
PB:3.07
PE(LYR):-1.70

Loading ...

Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 14, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dec 11, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Jun 22, 2023

Major Issues Report

Form 8-K - Current report
Jun 02, 2023

Major Issues Report

Form 8-K - Current report
May 24, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 24, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 20, 2023

Major Issues Report

Form 8-K - Current report
May 18, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 17, 2023

Major Issues Report

Form 8-K - Current report
May 08, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 15, 2023

Major Issues Report

8-K - Current report
Mar 15, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 15, 2023

Major Issues Report

8-K - Current report